| Joyful Noise Speech Therapy, Llc | |
|
5427 Charlotte Dr, New Orleans, LA 70122-2625 | |
| (504) 507-0408 | |
| Not Available |
| Full Name | Joyful Noise Speech Therapy, Llc |
|---|---|
| Type | Facility |
| Speciality | Speech-language Pathologist |
| Location | 5427 Charlotte Dr, New Orleans, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023684404 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joyful Noise Speech Therapy, Llc 5427 Charlotte Dr, New Orleans, LA 70122-2625 Ph: () - | Joyful Noise Speech Therapy, Llc 5427 Charlotte Dr, New Orleans, LA 70122-2625 Ph: (504) 507-0408 |
News Archive
The technology, supported by an artificial intelligence (AI) algorithm, could help accelerate clinical trials, and eventually may be used in detection and diagnostics, according to the Wellcome-funded study published today in Expert Review of Molecular Diagnostics.
Opioid addiction is among the biggest medical conditions troubling the U.S. today, and is far from reaching a solution. In 2017, it claimed almost 50 deaths per 100,000 in the state of West Virginia – the highest drug-overdose-related death rate in the US. Today, however, there is a gleam of hope from a new trial of an old technology to help fight this battle – a brain-embedded chip to counter opioid-induced cravings in treatment-refractory patients.
Arrowhead Research Corporation, a targeted therapeutics company, today announced that the first patient has been dosed in a Phase 1 clinical trial with Adipotide, a new class of treatment for obesity.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that it has signed a letter of agreement with Viropro, Inc., for the development of a biosimilar version of the monoclonal antibody drug rituximab (marketed by Genentech/Roche). Worldwide sales of rituximab in 2009 in all indications, including non-Hodgkin's lymphoma and chronic lymphocytic lymphoma, were approximately $5.6 billion.
Touchstone Medical, a specialist supplier of medical products to the gynaecology healthcare sector, is pleased to announce the launch of the Orchid, an innovative new disposable gynaecology speculum to the UK market.
› Verified 7 days ago
Mrs. Katherine Noto Gibbs, M.C.D., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 249 16th St, New Orleans, LA 70124 Phone: 504-390-7721 | |
Ellen Tindol Whittington, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8300 Earhart Blvd # 100, New Orleans, LA 70118 Phone: 504-866-6990 | |
Mrs. Denise Obst, MCD, CCC, L-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10001 Lake Forest Blvd Ste 201, New Orleans, LA 70127 Phone: 504-309-2230 | |
Keita J Gant, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10001 Lake Forest Blvd, Suite 820, New Orleans, LA 70127 Phone: 504-342-5368 | |
Yvette Peevy, SP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-4000 | |
Susan Pancamo, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1900 Gravier St, Room 6b21, New Orleans, LA 70112 Phone: 504-568-4250 Fax: 504-568-4249 | |
Erin Marie Arnold, MCD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 171 Valerie St, New Orleans, LA 70123 Phone: 504-451-1729 |